Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

BACKGROUND: Immune checkpoint inhibitors (ICPi) are a novel and promising anti-cancer therapy. There are limited data on the incidence, risk factors and outcomes of acute kidney injury (AKI) in patients receiving ICPi. METHODS: We conducted a cohort study of patients receiving ICPi at our center bet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Immunother Cancer
Hauptverfasser: Meraz-Muñoz, Alejandro, Amir, Eitan, Ng, Pamela, Avila-Casado, Carmen, Ragobar, Claire, Chan, Christopher, Kim, Joseph, Wald, Ron, Kitchlu, Abhijat
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2020
Schlagworte:
Clinical/Translational Cancer Immunotherapy
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7326260/
https://ncbi.nlm.nih.gov/pubmed/32601079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000467
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge